Evaluating Symptom Management Educational Materials for Patients With Prostate Cancer

Study Overview
=================
Brief Summary
-----------------
RATIONALE: Collecting feedback from patients with prostate cancer may help doctors develop better symptom management educational materials for patients. PURPOSE: This clinical trial is evaluating symptom management educational materials for patients with prostate cancer.

Detailed Description
-----------------
OBJECTIVES: To collect formative evaluation data about a new educational intervention using focus groups of patients with prostate cancer. To use the focus group data in the master's research paper of a Baylor College of Medicine physician-assistant student who is documenting the process of organizing and conducting the focus groups, enumerating areas where the new materials are deemed problematic, and identifying themes in the comments made by the focus group participants. OUTLINE: Study participants are assigned to 1 of 3 focus groups according to educational level and ethnicity (i.e., lower educational-level African-American men primarily from the Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC); lower educational-level Caucasian men from MEDVAMC, Baylor College of Medicine (BCM), or the community; or higher educational-level Caucasian men primarily from BCM or the community). Participants review written patient educational-intervention materials on prostate cancer and provide feedback to the investigator on the content and acceptability of these materials during a 1½-2-hour focus group discussion. Feedback data are used to revise the intervention materials so that they are appropriate to the target population.

Official Title
-----------------
FOCUS GROUP EVALUATION OF PROSTATE CANCER SYMPTOM MANAGEMENT EDUCATION MATERIALS

Conditions
-----------------
Prostate Cancer

Intervention / Treatment
-----------------
* Other: educational intervention
* Other: study of socioeconomic and demographic variables


Participation Criteria
=================
Eligibility Criteria
-----------------
DISEASE CHARACTERISTICS: Biopsy-proven prostate cancer Localized disease that has been previously treated Selected for participation from 1 of the following: Convenience sample of men from the Baylor College of Medicine (BCM) Urology clinics at Scurlock Tower (including the Urology clinic at MEDVAMC) and local prostate cancer-support groups Prostate cancer survivors who participated in the US TOO Father's Day Walk/Run or the Gay Pride Celebration PATIENT CHARACTERISTICS: Able to speak and read in English Willing to review the written patient educational materials and discuss them in a group setting PRIOR CONCURRENT THERAPY: See Disease Characteristics

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
Male

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Health Services Research
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| No Intervention: Focus group<br> | Other: educational intervention<br> <br> Other: study of socioeconomic and demographic variables<br> <br> |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Acceptability of the written patient educational materials, in terms of text size, white space, font, and graphics |  | Single timepoint | 
| Formative evaluation of the new educational materials, in terms of the comments made by the focus group participants |  | Single timepoint | 
| Validation that the goals of the educational-intervention instruction are being achieved |  | Single timepoint | 
| Improvement of the educational-intervention instruction by identification and remediation of problems |  | Single timepoint | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
stage I prostate cancer, stage IIB prostate cancer, stage IIA prostate cancer